Boy George this week has been nuts.
I haven't had as much time to work on the GEX tool as I had hoped but I did get some work done on testing it.
Check it out at https://www.spyvsgme.com/
A lot of gamma exposure rolled off this week and brought the gamma zero strike from 140 down to 125 and a 2.3M GEX.
Price target of 125 this week seems reasonable as total GEX has rolled positive.
Could see some relief rallies next week in the indexes as a metric ton of negative gamma exposure rolled off indexes and big names like Tesla.
Gamma Zero targets for next week look this
GME 104 -> 125
TSLA 936 -> 1045
AAPL 161 -> 165
SPY 437 -> 465
FOMC next week, if JPow remains hawkish we could see even deeper sell offs on indexes.
In that case I would be looking for lower targets. SPX still has nearly -1B GEX
GME 104 -> 100
TSLA 936 -> 900
AAPL 161 -> 160
SPY 437 -> 425
Not financial Advice. Just GEX
I haven't had as much time to work on the GEX tool as I had hoped but I did get some work done on testing it.
Check it out at https://www.spyvsgme.com/
A lot of gamma exposure rolled off this week and brought the gamma zero strike from 140 down to 125 and a 2.3M GEX.
Price target of 125 this week seems reasonable as total GEX has rolled positive.
Could see some relief rallies next week in the indexes as a metric ton of negative gamma exposure rolled off indexes and big names like Tesla.
Gamma Zero targets for next week look this
GME 104 -> 125
TSLA 936 -> 1045
AAPL 161 -> 165
SPY 437 -> 465
FOMC next week, if JPow remains hawkish we could see even deeper sell offs on indexes.
In that case I would be looking for lower targets. SPX still has nearly -1B GEX
GME 104 -> 100
TSLA 936 -> 900
AAPL 161 -> 160
SPY 437 -> 425
Not financial Advice. Just GEX
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.